- Why Cryoport
- Who We Serve
- About Us
- News & Events
- Investor Relations
- Contact Us
Are your advanced therapy supply chains ready for this year’s 4G/LTE data management transition?
A leap forward in standardizing the regenerative medicine supply chain
Update: President Biden signed Proclamation 10326 To Modify the Harmonized Tariff Schedule of the United States and for Other Purposes on December 23rd, 2021. Thus, Customs and Border Protection (CBP) has made January 27th, 2022 the effective date for all changes to the US tariff schedule.
Every five years the World Customs Organization (WCO) conducts a general review of the Harmonized Commodity Description and Coding System (Harmonized System or HS- refer to Appendix A). The WCO is an international body made up of representatives from 183 customs administrations around the world. These reviews are designed to keep the HS current with new technology, visibility into product streams and emerging global issues.
Biotech companies continue to innovate cutting-edge therapeutics, and the companies that support their efforts continue to strive for best practices as these new therapies advance and evolve. In the field of advanced therapy logistics, a risk-averse culture with a zero-failure tolerance mindset sits at the heart of innovative thinking and a dedication to always improving.